DataMeds AI buys Helomics cancer diagnostics lab from Axe Compute for USD 1.5 million - MEDS News | RalliesDataMeds AI buys Helomics cancer diagnostics lab from Axe Compute for USD 1.5 million
M
MEDS• Helomics acquisition completed
- DataMEDS AI completed the acquisition of Helomics, a Pittsburgh-based AI cancer diagnostics lab, from Axe Compute on Sept. 15, 2026.
- Purchase price totaled $1.5 million, paid with DataMEDS common shares and an acquisition note.
- Assets include a CLIA/CAP-certified clinical laboratory, related equipment, and a precision oncology CRO central lab services business.
- The deal also transferred $1.5 million in cash; Helomics came with no third-party debt requiring repayment.
- The transaction broadens DataMEDS into oncology, with plans to expand beyond tumor profiling into cancer screening and traditional CLIA lab services.
GS
•
